Literature DB >> 25448088

Animal models of viral hemorrhagic fever.

Darci R Smith1, Michael R Holbrook2, Brian B Gowen3.   

Abstract

The term "viral hemorrhagic fever" (VHF) designates a syndrome of acute febrile illness, increased vascular permeability and coagulation defects which often progresses to bleeding and shock and may be fatal in a significant percentage of cases. The causative agents are some 20 different RNA viruses in the families Arenaviridae, Bunyaviridae, Filoviridae and Flaviviridae, which are maintained in a variety of animal species and are transferred to humans through direct or indirect contact or by an arthropod vector. Except for dengue, which is transmitted among humans by mosquitoes, the geographic distribution of each type of VHF is determined by the range of its animal reservoir. Treatments are available for Argentine HF and Lassa fever, but no approved countermeasures have been developed against other types of VHF. The development of effective interventions is hindered by the sporadic nature of most infections and their occurrence in geographic regions with limited medical resources. Laboratory animal models that faithfully reproduce human disease are therefore essential for the evaluation of potential vaccines and therapeutics. The goal of this review is to highlight the current status of animal models that can be used to study the pathogenesis of VHF and test new countermeasures.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Animal models; Medical countermeasures; Non-human primates; Rodents; Viral hemorrhagic fever

Mesh:

Substances:

Year:  2014        PMID: 25448088     DOI: 10.1016/j.antiviral.2014.10.001

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  16 in total

Review 1.  Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies.

Authors:  Brian B Gowen; Brady T Hickerson
Journal:  J Microbiol       Date:  2017-02-28       Impact factor: 3.422

2.  Identification of a Locus in Mice that Regulates the Collateral Damage and Lethality of Virus Infection.

Authors:  Ichiro Misumi; Kevin D Cook; Joseph E Mitchell; Makayla M Lund; Sarah C Vick; Robert H Lee; Toru Uchimura; Wolfgang Bergmeier; Piotr Mieczkowski; Fernando Pardo-Manuel de Villena; Jenny P Y Ting; Jason K Whitmire
Journal:  Cell Rep       Date:  2019-04-30       Impact factor: 9.423

Review 3.  Immunobiology of Ebola and Lassa virus infections.

Authors:  Joseph B Prescott; Andrea Marzi; David Safronetz; Shelly J Robertson; Heinz Feldmann; Sonja M Best
Journal:  Nat Rev Immunol       Date:  2017-01-23       Impact factor: 53.106

4.  Rift Valley fever virus infection in golden Syrian hamsters.

Authors:  Dionna Scharton; Arnaud J Van Wettere; Kevin W Bailey; Zachary Vest; Jonna B Westover; Venkatraman Siddharthan; Brian B Gowen
Journal:  PLoS One       Date:  2015-01-21       Impact factor: 3.240

5.  MP-12 virus containing the clone 13 deletion in the NSs gene prevents lethal disease when administered after Rift Valley fever virus infection in hamsters.

Authors:  Brian B Gowen; Jonna B Westover; Eric J Sefing; Kevin W Bailey; Shoko Nishiyama; Luci Wandersee; Dionna Scharton; Kie-Hoon Jung; Tetsuro Ikegami
Journal:  Front Microbiol       Date:  2015-06-29       Impact factor: 5.640

6.  Potent inhibition of arenavirus infection by a novel fusion inhibitor.

Authors:  Brian B Gowen; Shibani Naik; Jonna B Westover; Eric R Brown; Vidyasagar R Gantla; Alexandra Fetsko; Ashley L Dagley; Dallan J Blotter; Nicole Anderson; Ken McCormack; Greg Henkel
Journal:  Antiviral Res       Date:  2021-06-29       Impact factor: 10.103

Review 7.  Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses.

Authors:  Joseph W Golden; Christopher D Hammerbeck; Eric M Mucker; Rebecca L Brocato
Journal:  Biomed Res Int       Date:  2015-07-21       Impact factor: 3.411

8.  The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.

Authors:  David Safronetz; Kyle Rosenke; Jonna B Westover; Cynthia Martellaro; Atsushi Okumura; Yousuke Furuta; Joan Geisbert; Greg Saturday; Takashi Komeno; Thomas W Geisbert; Heinz Feldmann; Brian B Gowen
Journal:  Sci Rep       Date:  2015-10-12       Impact factor: 4.379

Review 9.  Exploring the Immunopathogenesis of Viral Hemorrhagic Fever in Mice with a Humanized Immune System.

Authors:  Günther Schönrich; Martin J Raftery
Journal:  Front Immunol       Date:  2017-09-26       Impact factor: 7.561

10.  Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies.

Authors:  Vincent Madelain; Sylvain Baize; Frédéric Jacquot; Stéphanie Reynard; Alexandra Fizet; Stephane Barron; Caroline Solas; Bruno Lacarelle; Caroline Carbonnelle; France Mentré; Hervé Raoul; Xavier de Lamballerie; Jérémie Guedj
Journal:  Nat Commun       Date:  2018-10-01       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.